Monday, March 30, 2015

Early stage NSCLC patients with low tumor metabolic activity have longer survival

Low pre-surgery uptake of a labeled glucose analogue, a marker of metabolic activity, in the primary tumor of patients with stage I non-small cell lung cancer is associated with increased overall survival and a longer time before tumor recurrence, a study shows. Patients with high labeled glucose uptake may benefit from additional therapy following surgery.







from Top Health News — ScienceDaily http://bit.ly/1Fa99Kn via Naturally Increase Breast Size At Home

from Tumblr http://bit.ly/1BXnwwO

No comments:

Post a Comment